Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 220.91
MED's Cash to Debt is ranked higher than
79% of the 917 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.78 vs. MED: 220.91 )
Ranked among companies with meaningful Cash to Debt only.
MED' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 1.72 Max: N/A
Current: 220.91
Equity to Asset 0.76
MED's Equity to Asset is ranked higher than
89% of the 897 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.47 vs. MED: 0.76 )
Ranked among companies with meaningful Equity to Asset only.
MED' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.73 Max: 0.8
Current: 0.76
0.26
0.8
F-Score: 8
Z-Score: 12.42
M-Score: -3.41
WACC vs ROIC
8.01%
72.25%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.98
MED's Operating margin (%) is ranked higher than
78% of the 908 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.57 vs. MED: 9.98 )
Ranked among companies with meaningful Operating margin (%) only.
MED' s Operating margin (%) Range Over the Past 10 Years
Min: 6.52  Med: 10.38 Max: 12.28
Current: 9.98
6.52
12.28
Net-margin (%) 4.69
MED's Net-margin (%) is ranked higher than
68% of the 908 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.26 vs. MED: 4.69 )
Ranked among companies with meaningful Net-margin (%) only.
MED' s Net-margin (%) Range Over the Past 10 Years
Min: 4.45  Med: 6.46 Max: 7.61
Current: 4.69
4.45
7.61
ROE (%) 15.18
MED's ROE (%) is ranked higher than
76% of the 894 Companies
in the Global Specialty Retail industry.

( Industry Median: 7.05 vs. MED: 15.18 )
Ranked among companies with meaningful ROE (%) only.
MED' s ROE (%) Range Over the Past 10 Years
Min: 11.82  Med: 19.85 Max: 32.75
Current: 15.18
11.82
32.75
ROA (%) 11.00
MED's ROA (%) is ranked higher than
87% of the 917 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.06 vs. MED: 11.00 )
Ranked among companies with meaningful ROA (%) only.
MED' s ROA (%) Range Over the Past 10 Years
Min: 9.54  Med: 14.29 Max: 24.98
Current: 11
9.54
24.98
ROC (Joel Greenblatt) (%) 82.75
MED's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 913 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.87 vs. MED: 82.75 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MED' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 24.47  Med: 52.34 Max: 102.5
Current: 82.75
24.47
102.5
Revenue Growth (3Y)(%) 2.10
MED's Revenue Growth (3Y)(%) is ranked lower than
52% of the 753 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.70 vs. MED: 2.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MED' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -45.9  Med: 30.85 Max: 63.6
Current: 2.1
-45.9
63.6
EBITDA Growth (3Y)(%) 6.00
MED's EBITDA Growth (3Y)(%) is ranked higher than
60% of the 636 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.70 vs. MED: 6.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MED' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 6  Med: 25.25 Max: 78.8
Current: 6
6
78.8
EPS Growth (3Y)(%) 8.10
MED's EPS Growth (3Y)(%) is ranked higher than
63% of the 590 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.10 vs. MED: 8.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MED' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.4  Med: 23.60 Max: 68.6
Current: 8.1
-11.4
68.6
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

MED Guru Trades in Q1 2015

James Barrow 83,022 sh (New)
Jim Simons 380,100 sh (+23.49%)
Chuck Royce 1,400 sh (-36.36%)
» More
Q2 2015

MED Guru Trades in Q2 2015

Jim Simons 544,925 sh (+43.36%)
James Barrow 87,767 sh (+5.72%)
Chuck Royce 1,400 sh (unchged)
» More
Q3 2015

MED Guru Trades in Q3 2015

Jim Simons 588,500 sh (+8.00%)
James Barrow 87,784 sh (+0.02%)
Chuck Royce 1,400 sh (unchged)
» More
Q4 2015

MED Guru Trades in Q4 2015

James Barrow 90,384 sh (+2.96%)
Chuck Royce Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 26.88
MED's P/E(ttm) is ranked lower than
66% of the 1064 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.35 vs. MED: 26.88 )
Ranked among companies with meaningful P/E(ttm) only.
MED' s P/E(ttm) Range Over the Past 10 Years
Min: 8.98  Med: 21.74 Max: 61.03
Current: 26.88
8.98
61.03
Forward P/E 15.31
MED's Forward P/E is ranked lower than
57% of the 674 Companies
in the Global Specialty Retail industry.

( Industry Median: 14.18 vs. MED: 15.31 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 18.87
MED's PE(NRI) is ranked lower than
51% of the 803 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.10 vs. MED: 18.87 )
Ranked among companies with meaningful PE(NRI) only.
MED' s PE(NRI) Range Over the Past 10 Years
Min: 8.97  Med: 20.34 Max: 61.23
Current: 18.87
8.97
61.23
P/B 3.81
MED's P/B is ranked lower than
86% of the 1157 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.41 vs. MED: 3.81 )
Ranked among companies with meaningful P/B only.
MED' s P/B Range Over the Past 10 Years
Min: 1.36  Med: 3.79 Max: 10.95
Current: 3.81
1.36
10.95
P/S 1.28
MED's P/S is ranked lower than
79% of the 1157 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.56 vs. MED: 1.28 )
Ranked among companies with meaningful P/S only.
MED' s P/S Range Over the Past 10 Years
Min: 0.49  Med: 1.28 Max: 4.81
Current: 1.28
0.49
4.81
PFCF 14.44
MED's PFCF is ranked higher than
65% of the 744 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.53 vs. MED: 14.44 )
Ranked among companies with meaningful PFCF only.
MED' s PFCF Range Over the Past 10 Years
Min: 8.43  Med: 16.73 Max: 165
Current: 14.44
8.43
165
POCF 12.08
MED's POCF is ranked higher than
52% of the 997 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.50 vs. MED: 12.08 )
Ranked among companies with meaningful POCF only.
MED' s POCF Range Over the Past 10 Years
Min: 5.47  Med: 12.27 Max: 51.82
Current: 12.08
5.47
51.82
EV-to-EBIT 9.73
MED's EV-to-EBIT is ranked higher than
71% of the 1137 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.42 vs. MED: 9.73 )
Ranked among companies with meaningful EV-to-EBIT only.
MED' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.8  Med: 11.70 Max: 38.8
Current: 9.73
4.8
38.8
EV-to-EBITDA 7.62
MED's EV-to-EBITDA is ranked higher than
67% of the 1157 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.46 vs. MED: 7.62 )
Ranked among companies with meaningful EV-to-EBITDA only.
MED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.9  Med: 8.60 Max: 29.4
Current: 7.62
3.9
29.4
PEG 1.59
MED's PEG is ranked lower than
52% of the 323 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.50 vs. MED: 1.59 )
Ranked among companies with meaningful PEG only.
MED' s PEG Range Over the Past 10 Years
Min: 0.22  Med: 0.75 Max: 4.17
Current: 1.59
0.22
4.17
Shiller P/E 27.76
MED's Shiller P/E is ranked lower than
67% of the 347 Companies
in the Global Specialty Retail industry.

( Industry Median: 18.57 vs. MED: 27.76 )
Ranked among companies with meaningful Shiller P/E only.
MED' s Shiller P/E Range Over the Past 10 Years
Min: 17.5  Med: 34.85 Max: 112.29
Current: 27.76
17.5
112.29
Current Ratio 3.95
MED's Current Ratio is ranked higher than
89% of the 903 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.55 vs. MED: 3.95 )
Ranked among companies with meaningful Current Ratio only.
MED' s Current Ratio Range Over the Past 10 Years
Min: 0.99  Med: 3.27 Max: 6.73
Current: 3.95
0.99
6.73
Quick Ratio 3.40
MED's Quick Ratio is ranked higher than
92% of the 903 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.84 vs. MED: 3.40 )
Ranked among companies with meaningful Quick Ratio only.
MED' s Quick Ratio Range Over the Past 10 Years
Min: 0.46  Med: 2.30 Max: 4.52
Current: 3.4
0.46
4.52
Days Inventory 70.62
MED's Days Inventory is ranked higher than
60% of the 863 Companies
in the Global Specialty Retail industry.

( Industry Median: 86.91 vs. MED: 70.62 )
Ranked among companies with meaningful Days Inventory only.
MED' s Days Inventory Range Over the Past 10 Years
Min: 79.81  Med: 99.39 Max: 174.69
Current: 70.62
79.81
174.69
Days Sales Outstanding 2.49
MED's Days Sales Outstanding is ranked higher than
85% of the 692 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.65 vs. MED: 2.49 )
Ranked among companies with meaningful Days Sales Outstanding only.
MED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.88  Med: 1.96 Max: 8.96
Current: 2.49
0.88
8.96

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.89
MED's Dividend Yield is ranked lower than
83% of the 1050 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.31 vs. MED: 0.89 )
Ranked among companies with meaningful Dividend Yield only.
MED' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.91
Current: 0.89
0
0.91
Forward Dividend Yield 3.59
MED's Forward Dividend Yield is ranked higher than
69% of the 945 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.56 vs. MED: 3.59 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.89
MED's Yield on cost (5-Year) is ranked lower than
83% of the 1070 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.84 vs. MED: 0.89 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MED' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0.91
Current: 0.89
0
0.91
3-Year Average Share Buyback Ratio 3.50
MED's 3-Year Average Share Buyback Ratio is ranked higher than
91% of the 517 Companies
in the Global Specialty Retail industry.

( Industry Median: -0.50 vs. MED: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -19.8  Med: -5.55 Max: 3.5
Current: 3.5
-19.8
3.5

Valuation & Return

vs
industry
vs
history
Price/Net Cash 8.54
MED's Price/Net Cash is ranked higher than
57% of the 155 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.29 vs. MED: 8.54 )
Ranked among companies with meaningful Price/Net Cash only.
MED' s Price/Net Cash Range Over the Past 10 Years
Min: 8.11  Med: 19.70 Max: 382.25
Current: 8.54
8.11
382.25
Price/Net Current Asset Value 5.81
MED's Price/Net Current Asset Value is ranked lower than
58% of the 689 Companies
in the Global Specialty Retail industry.

( Industry Median: 7.56 vs. MED: 5.81 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MED' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 5.25  Med: 10.94 Max: 164.67
Current: 5.81
5.25
164.67
Price/Tangible Book 3.83
MED's Price/Tangible Book is ranked lower than
72% of the 1149 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.96 vs. MED: 3.83 )
Ranked among companies with meaningful Price/Tangible Book only.
MED' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.11  Med: 3.92 Max: 23.94
Current: 3.83
1.11
23.94
Price/Projected FCF 1.06
MED's Price/Projected FCF is ranked higher than
52% of the 814 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.03 vs. MED: 1.06 )
Ranked among companies with meaningful Price/Projected FCF only.
MED' s Price/Projected FCF Range Over the Past 10 Years
Min: 1  Med: 3.20 Max: 11.53
Current: 1.06
1
11.53
Price/DCF (Earnings Based) 0.66
MED's Price/DCF (Earnings Based) is ranked higher than
83% of the 184 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.22 vs. MED: 0.66 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.98
MED's Price/Median PS Value is ranked lower than
57% of the 1156 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.00 vs. MED: 0.98 )
Ranked among companies with meaningful Price/Median PS Value only.
MED' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.18  Med: 1.01 Max: 4.75
Current: 0.98
0.18
4.75
Price/Peter Lynch Fair Value 3.68
MED's Price/Peter Lynch Fair Value is ranked lower than
87% of the 341 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.38 vs. MED: 3.68 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MED' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.41  Med: 0.93 Max: 3.61
Current: 3.68
0.41
3.61
Price/Graham Number 1.79
MED's Price/Graham Number is ranked lower than
59% of the 1010 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.21 vs. MED: 1.79 )
Ranked among companies with meaningful Price/Graham Number only.
MED' s Price/Graham Number Range Over the Past 10 Years
Min: 0.24  Med: 1.94 Max: 6.32
Current: 1.79
0.24
6.32
Earnings Yield (Greenblatt) (%) 10.22
MED's Earnings Yield (Greenblatt) (%) is ranked higher than
76% of the 887 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.90 vs. MED: 10.22 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MED' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.6  Med: 8.50 Max: 20.7
Current: 10.22
2.6
20.7
Forward Rate of Return (Yacktman) (%) 11.51
MED's Forward Rate of Return (Yacktman) (%) is ranked higher than
63% of the 509 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.77 vs. MED: 11.51 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MED' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 10.7  Med: 31.30 Max: 57.1
Current: 11.51
10.7
57.1

More Statistics

Revenue(Mil) $274
EPS $ 1.05
Beta0.82
Short Percentage of Float9.47%
52-Week Range $26.14 - 33.66
Shares Outstanding(Mil)11.76

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 273 278
EPS($) 1.72 1.82
EPS without NRI($) 1.72 1.82

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail
Compare:TSCO, AMZN, EBAY, FIVE, AZO » details
Traded in other countries:MDF.Germany,
Medifast Inc is a Delaware Corporation, incorporated in 1993. The Company is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins. Its products and services are sold to weight loss program participants via the Internet, telephone, and brick and mortar clinics. It operates in two reportable segments; Medifast, and MWCC and Wholesale. The Medifast segment consists of the sales from Medifast Direct Marketing and Take Shape For Life. The MWCC and Wholesale segment consists of the sales of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians and international sales. Medifast Weight Control Centers is the brick and mortar clinic channel of the Company with affiliate-owned locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia. Medifast Weight Control Centers offer a high-touch model including comprehensive Companys programs for weight loss and maintenance, customized client counseling, an InBody body composition analysis, and monitoring with a BodyGem indirect calorimeter that determines resting metabolic rates. In the direct-to-consumer channel, Medifast Direct, customers order its product directly through the Companys website, www.medifast1.com or its in-house call center. Take Shape For Life is the personal coaching division of the Company. It enriches lives by providing clinically proven weight loss and weight management products and programs. It offers clinically proven products and programs for weight management, weight maintenance, and long-term health through multiple channels of distribution. It offers a variety of weight loss and weight management products under the Medifast and Essential 1 brands and for select private label customers. Its line includes more than 75 options, including, but not limited to bars, bites, pretzels, puffs, cereal crunch, drinks, eggs, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company continues to build and leverage its core brand through multiple marketing strategies for each of its distinct distribution channels such as Medifast Direct, Medical Wholesale, Medifast Weight Control Centers, and Take Shape For Life to their target audiences. It has also developed a comprehensive social media strategy utilizing Facebook, Twitter, YouTube, blogger endorsements, and more. The Company competes with NutriSystem Inc., Herbalife Ltd., USANA Health Sciences, and Weight Watchers International, Inc. The formulation, processing, packaging, and labeling of the Company's products is subject to regulation by several federal agencies, but principally by the FDA.
» More Articles for MED

Headlines

Articles On GuruFocus.com

More From Other Websites
Former Medifast CEO's Baltimore meal delivery startup to launch on East Coast in March Feb 08 2016
Medifast® Announces Latest Industry and Community Recognitions for Chairman & Chief Executive... Feb 02 2016
Coverage initiated on Medifast by Wunderlich Jan 29 2016
Medifast Announces Launch Of New Product Line, Investors Shrug Off News Jan 20 2016
Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer... Jan 20 2016
Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer... Jan 20 2016
MEDIFAST INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Jan 19 2016
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 13 2016
The Top 3 ETFs For Investing in Italy Jan 12 2016
Take Shape For Life® Kicks-Off New Year with Success Stories Featured in People Magazine's Annual... Jan 11 2016
Medifast is about to branch into sports nutrition Jan 08 2016
Medifast® Declares 2016 "Your Year" in New Ad Campaign Jan 07 2016
Medifast, Inc. to Participate in the 18th Annual ICR Conference Jan 04 2016
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : December 30, 2015 Dec 30 2015
Medifast, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015
New Year's Resolution Season Busy Time for Weight Loss Industry, Says Medifast CEO Dec 21 2015
MEDIFAST INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 16 2015
Medifast, Inc. Announces Initiation of Quarterly Dividend Dec 16 2015
Medifast, Inc. Announces Initiation of Quarterly Dividend Dec 16 2015
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 09 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK